Review estimates 69% 3-dose vaccine efficacy against long COVID | CIDRAP
Studies on Vaccines & Effectiveness
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Impact Of Covid-19 Vaccination On The Risk Of Developing Long-Covid And On Existing Long-Covid Symptoms
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel | NEJM
Coronavirus: Covid News: Israeli Study Says Second Booster Protects Against Omicron Infection but Wanes Fast (Published 2022)
Covid-19: Vaccination Reduces Severity and Duration of Long Covid
Vaccination, Paxlovid decrease risk of long Covid, studies show | CNN
The Risks Of Pots After Covid-19 Vaccination And Sars-Cov-2 Infection: It’s Worth A Shot
The bivalent vaccine booster outperforms
COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster